Trypsin-Treated β-Lactoglobulin Improves Glucose Tolerance in C57BL/6 Mice by Enhancing AMPK Activation and Glucose Uptake in Hepatocytes

Biological & Pharmaceutical Bulletin
Yuichi TsudaMakoto Yamaguchi

Abstract

It was reported that trypsin-treated β-lactoglobulin (β-LG) had a glucose-lowering effect in the oral glucose tolerance test (OGTT) in mice and a dipeptidyl peptidase-4 (DPP-4) inhibition activity in vitro. However, whether trypsin-treated β-LG improves glucose tolerance by inhibiting DPP-4 in vivo has not yet been examined, and the mechanism of the glucose-lowering effect of trypsin-treated β-LG is thus unclear. Here we investigated the detailed mechanism underlying the glucose tolerance effect of trypsin-treated β-LG. The oral administration of trypsin-treated β-LG significantly decreased the blood glucose concentrations in both the OGTT and an intraperitoneal glucose tolerance test (IPGTT). However, trypsin-treated β-LG did not increase the insulin secretion after glucose loading. Trypsin-treated β-LG potently increased the level of phosphorylated AMP-activated protein kinase (AMPK) in human hepatocellular carcinoma (HepG2) cells and in mice hepatocytes. Moreover, trypsin-treated β-LG significantly enhanced glucose uptake into the HepG2 cells. These results indicate that trypsin-treated β-LG decreases blood glucose levels after glucose loading by upregulating AMPK activation and glucose uptake in the liver, which could contr...Continue Reading

References

Aug 31, 1995·The New England Journal of Medicine·M StumvollJ E Gerich
Aug 13, 1999·The American Journal of Physiology·R R RussellL H Young
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
Sep 15, 2009·Best Practice & Research. Clinical Endocrinology & Metabolism·Nancy A Thornberry, Baptist Gallwitz
Feb 20, 2010·Journal of Diabetes Science and Technology·Leann Olansky
Jan 18, 2011·Diabetes & Metabolism·M BouchouchaR Cohen
Feb 4, 2011·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Murielle BortolottiLuc Tappy
Aug 13, 2011·Journal of Pharmacological Sciences·Masayuki UchidaOrie Mogami
Nov 2, 2012·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Angela ChaléRoger A Fielding
Dec 15, 2012·World Journal of Gastroenterology : WJG·Sumera KarimPatricia F Lalor
Dec 21, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Mar 19, 2014·Diabetes Research and Clinical Practice·L GuariguataJ E Shaw
Jul 16, 2014·European Journal of Nutrition·Noriko Ichinoseki-SekineHisashi Naito
Nov 1, 2006·The Journal of Clinical Hypertension·Joel J Pins, Joseph M Keenan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.